Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO): process of adapting collaborative care for co-occurring opioid use and mental disorders

Karen Chan Osilla, Alex R Dopp, Katherine E Watkins, Venice Ceballos, Brian Hurley, Lisa S Meredith, Isabel Leamon, Vanessa Jacobsohn, Miriam Komaromy, Karen Chan Osilla, Alex R Dopp, Katherine E Watkins, Venice Ceballos, Brian Hurley, Lisa S Meredith, Isabel Leamon, Vanessa Jacobsohn, Miriam Komaromy

Abstract

Background: Opioid use disorders (OUD), co-occurring with either depression and/or PTSD, are prevalent, burdensome, and often receive little or low-quality care. Collaborative care is a service delivery intervention that uses a team-based model to improve treatment access, quality, and outcomes in primary care patients, but has not been evaluated for co-occurring OUD and mental health disorders. To address this treatment and quality gap, we adapted collaborative care for co-occurring OUD and mental health disorders.

Methods: Our adapted model is called Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO). We used the five-step Map of Adaptation Process (McKleroy in AIDS Educ Prev 18:59-73, 2006) to develop the model. For each step, our stakeholder team of research and clinical experts, primary care partners, and patients provided input into adaptation processes (e.g., adaptation team meetings, clinic partner feedback, patient interviews and beta-testing). To document each adaptation and our decision-making process, we used the Framework for Reporting Adaptations and Modifications-Enhanced (Wiltsey Stirman in Implement Sci 14:1-10, 2019).

Results: We documented 12 planned fidelity-consistent adaptations to collaborative care, including a mix of content, context, and training/evaluation modifications intended to improve fit with the patient population (co-occurring disorders) or the New Mexico setting (low-resource clinics in health professional shortage areas). Examples of documented adaptations include use of community health workers as care coordinators; an expanded consultant team to support task-shifting to community health workers; modified training protocols for Problem-Solving Therapy and Written Exposure Therapy to incorporate examples of treating patients for depression or PTSD with co-occurring OUD; and having care coordinators screen for patients' social needs.

Conclusions: We completed the first three steps of the Map of Adaptation Process, resulting in a variety of adaptations that we believe will make collaborative care more acceptable and feasible in treating co-occurring OUD and mental health disorders. Future steps include evaluating the effectiveness of CLARO and documenting reactive and/or planned adaptations to the model that occur during its implementation and delivery. Trial registration NCT04559893, NCT04634279. Registered 08 September 2020, https://ichgcp.net/clinical-trials-registry/NCT04559893.

Keywords: Adaptation; Collaborative care; Community health workers; Depression; Opioid use disorder; Post-traumatic stress disorder; Primary care behavioral health.

Conflict of interest statement

None.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Summary of Adaptation Processes for the CLARO Intervention. CLARO: Collaboration Leading to Addiction Treatment and Recovery from Other Stresses. The five steps shown are from the Map of Adaptation Process [1]. Recursive arrows indicate the potential to revisit earlier steps as adaptation proceeds
Fig. 2
Fig. 2
Summary of Codes in the Framework for Reporting Adaptations and Modifications – Enhanced (FRAME) Coding System. This figure is adapted from Fig. 1 in Wiltsey-Stirman et al. [2]. The original article was distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided appropriate credit is given and any changes are noted. Our figure is a simplified version of the original, and our figure includes a new code we added for this project (Collaborative Care components)
Fig. 3
Fig. 3
Overview of the Adapted CLARO Collaborative Care Model. CLARO: Collaboration Leading to Addiction Treatment and Recovery from Other Stresses; CC: Care Coordinator. Figure is adapted from the NIH Helping to End Addiction Long-Term (HEAL) InitiativeSM
Fig. 4
Fig. 4
Summary of Goodness-of-Fit Considerations Identified in Map of Adaptation Process, Step 1: Assess Context. Based on the Map of Adaptation Process [1]. OUD: opioid use disorder; MDD: major depressive disorder; PTSD: post-traumatic stress disorder; FQHC: Federally Qualified Health Center; UNM: University of New Mexico

References

    1. McKleroy VS, Galbraith JS, Cummings B, Jones P, Harshbarger C, Collins C, et al. Adapting evidence–based behavioral interventions for new settings and target populations. AIDS Educ Prev. 2006;18:59–73. doi: 10.1521/aeap.2006.18.supp.59.
    1. Wiltsey Stirman S, Baumann AA, Miller CJ. The FRAME: an expanded framework for reporting adaptations and modifications to evidence-based interventions. Implement Sci. 2019;14(1):1–10. doi: 10.1186/s13012-019-0898-y.
    1. Barry DT, Cutter CJ, Beitel M, Kerns RD, Liong C, Schottenfeld RS. Psychiatric disorders among patients seeking treatment for co-occurring chronic pain and opioid use disorder. J Clin Psychiatry. 2016;77(10):1413–1419. doi: 10.4088/JCP.15m09963.
    1. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566–576. doi: 10.1001/archpsyc.64.5.566.
    1. Dore G, Mills K, Murray R, Teesson M, Farrugia P. Post-traumatic stress disorder, depression and suicidality in inpatients with substance use disorders. Drug Alcohol Rev. 2012;31(3):294–302. doi: 10.1111/j.1465-3362.2011.00314.x.
    1. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807–816. doi: 10.1001/archpsyc.61.8.807.
    1. Han B, Compton WM, Blanco C, Colpe LJ. Prevalence, treatment, and unmet treatment needs of US adults with mental health and substance use disorders. Health Aff. 2017;36(10):1739–1747. doi: 10.1377/hlthaff.2017.0584.
    1. Meier A, Lambert-Harris C, McGovern MP, Xie H, An M, McLeman B. Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity. Am J Drug Alcohol Abuse. 2014;40(4):304–311. doi: 10.3109/00952990.2014.910519.
    1. Mills KL, Teesson M, Ross J, Peters L. Trauma, PTSD, and substance use disorders: findings from the Australian national survey of mental health and well-being. Am J Psychiatry. 2006;163(4):652–658. doi: 10.1176/ajp.2006.163.4.652.
    1. Brown PJ, Recupero PR, Stout R. PTSD substance abuse comorbidity and treatment utilization. Addict Behav. 1995;20(2):251–254. doi: 10.1016/0306-4603(94)00060-3.
    1. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048–1060. doi: 10.1001/archpsyc.1995.03950240066012.
    1. Mills KL, Teesson M, Ross J, Darke S, Shanahan M. The costs and outcomes of treatment for opioid dependence associated with posttraumatic stress disorder. Psychiatr Serv. 2005;56(8):940–945. doi: 10.1176/appi.ps.56.8.940.
    1. Nunes EV, Sullivan MA, Levin FR. Treatment of depression in patients with opiate dependence. Biol Psychiatry. 2004;56(10):793–802. doi: 10.1016/j.biopsych.2004.06.037.
    1. Ouimette PC, Ahrens C, Moos RH, Finney JW. Posttraumatic stress disorder in substance abuse patients: relationship to 1-year posttreatment outcomes. Psychol Addict Behav. 1997;11(1):34. doi: 10.1037/0893-164X.11.1.34.
    1. Ouimette PC, Brown PJ, Najavits LM. Course and treatment of patients with both substance use and posttraumatic stress disorders. Addict Behav. 1998;23(6):785–795. doi: 10.1016/S0306-4603(98)00064-1.
    1. Fendrich M, Becker J, Hernandez-Meier J. Psychiatric symptoms and recent overdose among people who use heroin or other opioids: results from a secondary analysis of an intervention study. Addict Behav Rep. 2019;10:100212.
    1. Ilgen MA, Bohnert AS, Ignacio RV, McCarthy JF, Valenstein MM, Kim HM, et al. Psychiatric diagnoses and risk of suicide in veterans. Arch Gen Psychiatry. 2010;67(11):1152–1158. doi: 10.1001/archgenpsychiatry.2010.129.
    1. Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 2019;197:78–82. doi: 10.1016/j.drugalcdep.2018.12.030.
    1. Mościcki E, O'Carroll P, Rae D, Locke B, Roy A, Regier D. Suicide attempts in the Epidemiologic Catchment Area study. Yale J Biol Med. 1988;61(3):259–268.
    1. Darke S, Ross J, Marel C, Mills KL, Slade T, Burns L, et al. Patterns and correlates of attempted suicide amongst heroin users: 11-year follow-up of the Australian treatment outcome study cohort. Psychiatry Res. 2015;227(2–3):166–170. doi: 10.1016/j.psychres.2015.04.010.
    1. Ahmadi J, Jahromi MS, Ehsaei Z. The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial. Trials. 2018;19(1):462. doi: 10.1186/s13063-018-2843-9.
    1. Gordon AJ, Lo-Ciganic W-H, Cochran G, Gellad WF, Cathers T, Kelley D, et al. Patterns and quality of buprenorphine opioid agonist treatment in a large Medicaid program. J Addict Med. 2015;9(6):470–477. doi: 10.1097/ADM.0000000000000164.
    1. Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J Subst Abuse Treat. 2018;85:90–96. doi: 10.1016/j.jsat.2017.07.001.
    1. Samples H, Williams AR, Olfson M, Crystal S. Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees. J Subst Abuse Treat. 2018;95:9–17. doi: 10.1016/j.jsat.2018.09.001.
    1. Williams AR, Samples H, Crystal S, Olfson M. Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder. Am J Psychiatry. 2020;177(2):117–124. doi: 10.1176/appi.ajp.2019.19060612.
    1. Harris KM, Edlund MJ. Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatr Serv. 2005;56(8):954–959. doi: 10.1176/appi.ps.56.8.954.
    1. Priester MA, Browne T, Iachini A, Clone S, DeHart D, Seay KD. Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J Subst Abuse Treat. 2016;61:47–59. doi: 10.1016/j.jsat.2015.09.006.
    1. U.S. Department of Health and Human Services. Report to Congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders. Rockville: Substance Abuse and Mental Health Services Administration; 2002.
    1. Cherpitel CJ, Ye Y. Trends in alcohol- and drug-related emergency department and primary care visits: data from four U.S. national surveys (1995–2010) J Stud Alcohol Drugs. 2012;73(3):454–458. doi: 10.15288/jsad.2012.73.454.
    1. Pilowsky DJ, Wu LT. Screening for alcohol and drug use disorders among adults in primary care: a review. J Subst Abuse Rehabil. 2012;3(1):25–34.
    1. Alexander CL, Arnkoff DB, Glass CR. Bringing psychotherapy to primary care: innovations and challenges. Clin Psychol Sci Pract. 2010;17(3):191–214. doi: 10.1111/j.1468-2850.2010.01211.x.
    1. Beronio K, Po R, Skopec L. Affordable Care Act will expand mental health and substance use disorder benefits and parity protections for 62 million Americans. ASPE Research Brief. 2013. . Accessed 20 Feb.
    1. Buck JA. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Aff. 2011;30(8):1402–1410. doi: 10.1377/hlthaff.2011.0480.
    1. University of Washington, Psychiatry & Behavioral Sciences, Division of Population Health, AIMS Center. Principles of collaborative care. 2019. . Accessed 17 Mar 2020.
    1. Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166(21):2314–2321. doi: 10.1001/archinte.166.21.2314.
    1. Meredith LS, Eisenman DP, Han B, Green BL, Kaltman S, Wong EC, et al. Impact of collaborative care for underserved patients with PTSD in primary care: a randomized controlled trial. J Gen Intern Med. 2016;31:509–517. doi: 10.1007/s11606-016-3588-3.
    1. Brackett CD, Duncan M, Wagner JF, Fineberg L, Kraft S. Multidisciplinary treatment of opioid use disorder in primary care using the collaborative care model. Subst Abus. 2021;43(1):240–244. doi: 10.1080/08897077.2021.1932698.
    1. Watkins KE, Ober AJ, Lamp K, Lind M, Setodji C, Osilla KC, et al. Collaborative care for opioid and alcohol use disorders in primary care: The SUMMIT randomized clinical trial. JAMA Intern Med. 2017;177(10):1480–1488. doi: 10.1001/jamainternmed.2017.3947.
    1. Berenz EC, Coffey SF. Treatment of co-occurring posttraumatic stress disorder and substance use disorders. Curr Psychiatry Rep. 2012;14(5):469–477. doi: 10.1007/s11920-012-0300-0.
    1. Meredith LS, Komaromy MS, Cefalu M, Murray-Krezan C, Page K, Osilla KC, et al. Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder. Contemp Clin Trials. 2021;104:106354. doi: 10.1016/j.cct.2021.106354.
    1. New Mexico Department of Public Health. How New Mexico compares, 2019. 2019. . Accessed 2 July 2021.
    1. Damschroder LJ, Hagedorn HJ. A guiding framework and approach for implementation research in substance use disorders treatment. Psychol Addict Behav. 2011;25(2):194–205. doi: 10.1037/a0022284.
    1. Baumann A, Cabassa L, Stirman S. Adaptation in dissemination and implementation science. In: Brownson R, Colditz G, Proctor E, editors. Dissemination and implementation research in health: translating science to practice. 2. New York: Oxford University Press; 2018. pp. 285–300.
    1. Castro F, Barrera JM, Holleran SL. Issues and challenges in the design of culturally adapted evidence-based interventions. Annu Rev Clin Psychol. 2010;6:213–239. doi: 10.1146/annurev-clinpsy-033109-132032.
    1. United States Census Bureau. QuickFacts: New Mexico. 2020. . Accessed 2 July 2021.
    1. United States Census Bureau. American community survey (ACS). 2017. . Accessed 4 Mar 2019.
    1. Cargo M, Mercer SL. The value and challenges of participatory research: strengthening its practice. Annu Rev Public Health. 2008;29:325–350. doi: 10.1146/annurev.publhealth.29.091307.083824.
    1. Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med. 2022;292:114523. doi: 10.1016/j.socscimed.2021.114523.
    1. McNall M, Foster-Fishman PG. Methods of rapid evaluation, assessment, and appraisal. Am J Eval. 2007;28(2):151–168. doi: 10.1177/1098214007300895.
    1. Krippendorf K. Content analysis: an introduction to its methodology. Beverly Hills, CA: Sage; 1980.
    1. Weber RP. Basic content analysis. Newbury Park: Sage; 1990.
    1. Wiltsey Stirman S, Baumann AA, Miller CJ. FRAME coding manual. 2019. Accessed 2 July 2021.
    1. Stanford Medicine, The F.A.S.T. Lab. Adaptation: FRAME-IS for tracking implementation strategies. 2021. . Accessed 16 July 2021.
    1. University of Washington, Psychiatry & Behavioral Sciences, Division of Population Health, AIMS Center. Patient-centered integrated behavioral health care: Principles & tasks checklist. 2014. . Accessed 3 June 2020.
    1. Rural Health Information Hub. Health professional shortage areas: Primary care, by county, 2021 - New Mexico. 2020. Accessed 2 July 2021.
    1. Hartzler AL, Tuzzio L, Hsu C, Wagner EH. Roles and functions of community health workers in primary care. Ann Fam Med. 2018;16(3):240–245. doi: 10.1370/afm.2208.
    1. Renn BN, Mosser BA, Raue PJ. Problem-solving therapy. In: Tampi RR, Yarns BC, Zdanys KF, Tampi DJ, editors. Psychotherapy in later life. Cambridge: Cambridge University Press; 2020. pp. 75–91.
    1. Sloan DM, Marx BP. Written Exposure Therapy for PTSD: a brief treatment approach for mental health professionals. Washington.: American Psychological Association; 2019.
    1. Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015;28(6):489–498. doi: 10.1002/jts.22059.
    1. Pilkonis PA, Yu L, Dodds NE, Johnston KL, Lawrence SM, Hilton TF, et al. Item banks for substance use from the Patient-Reported Outcomes Measurement Information System (PROMIS(®)): Severity of use and positive appeal of use. Drug Alcohol Depend. 2015;156:184–192. doi: 10.1016/j.drugalcdep.2015.09.008.
    1. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary care evaluation of mental disorders Patient health questionnaire. JAMA. 1999;282(18):1737–1744. doi: 10.1001/jama.282.18.1737.
    1. Proctor E, Luke D, Calhoun A, McMillen C, Brownson R, McCrary S, et al. Sustainability of evidence-based healthcare: research agenda, methodological advances, and infrastructure support. Implement Sci. 2015;10(1):88. doi: 10.1186/s13012-015-0274-5.
    1. Shelton RC, Lee M. Sustaining evidence-based interventions and policies: recent innovations and future directions in implementation science. Am J Public Health. 2019;109:S132–S134. doi: 10.2105/AJPH.2018.304913.
    1. Carlo AD, Corage Baden A, McCarty RL, Ratzliff ADH. Early health system experiences with collaborative care (CoCM) billing codes: a qualitative study of leadership and support staff. J Gen Intern Med. 2019;34(10):2150–2158. doi: 10.1007/s11606-019-05195-0.
    1. Carlo AD, Drake L, Ratzliff AD, Chang D, Unützer J. Sustaining the collaborative care model (CoCM): billing newly available CoCM CPT codes in an academic primary care system. Psychiatr Serv. 2020;71(9):972–974. doi: 10.1176/appi.ps.201900581.
    1. Chlebowski C, Hurwich-Reiss E, Wright B, Brookman-Frazee L. Using stakeholder perspectives to guide systematic adaptation of an autism mental health intervention for Latinx families: a qualitative study. J Community Psychol. 2020;48(4):1194–1214. doi: 10.1002/jcop.22296.
    1. Poulsen MN, Vandenhoudt H, Wyckoff SC, Obong'o CO, Ochura J, Njika G, et al. Cultural adaptation of a US evidence-based parenting intervention for rural Western Kenya: from parents matter! To families matter! AIDS Educ Prev. 2010;22(4):273–285. doi: 10.1521/aeap.2010.22.4.273.
    1. Birken SA, Rohweder CL, Powell BJ, Shea CM, Scott J, Leeman J, et al. T-CaST: an implementation theory comparison and selection tool. Implement Sci. 2018;13(1):143. doi: 10.1186/s13012-018-0836-4.
    1. . Dissemination & implementation models in health research and practice. Undated. Accessed 11 Feb 2022.
    1. Kendall PC, Gosch E, Furr JM, Sood E. Flexibility within fidelity. J Am Acad Child Adolesc Psychiatry. 2008;47(9):987–993. doi: 10.1097/CHI.0b013e31817eed2f.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit